PLC GLAXOSMITHKLINE Insider Trading Transactions

Get the latest insider transactions of PLC GLAXOSMITHKLINE. PLC GLAXOSMITHKLINE is 10% Owner in QUEST DIAGNOSTICS INC ($DGX) and Director in QUEST DIAGNOSTICS INC ($DGX) and 10% Owner in EPIX Pharmaceuticals, Inc. ($EPIX) and 10% Owner in MAXYGEN INC ($MAXY) and 10% Owner in Innoviva, Inc. ($THRX) and in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and 10% Owner in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and in Liquidia Technologies Inc ($LQDA) and 10% Owner in Redpoint Bio CORP ($RPBC) and in NUPATHE INC. ($PATH) and 10% Owner in Anacor Pharmaceuticals, Inc. ($ANAC) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and in Principia Biopharma Inc. ($PRNB) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in Progyny, Inc. ($PGNY) and 10% Owner in Theravance Biopharma, Inc. ($TBPH) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Fulcrum Therapeutics, Inc. ($FULC) and 10% Owner in CRISPR Therapeutics AG ($CRSP) and 10% Owner in Spero Therapeutics, Inc. ($SPRO) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC) and Director in BICYCLE THERAPEUTICS plc ($BCYC) and Director in Nkarta, Inc. ($NKTX) and Director in Pandion Therapeutics, Inc. ($PAND).